跳至主要内容
临床试验/NCT05916989
NCT05916989已完成不适用

Stimulant Use and Methylation in HIV

Florida International University1 个研究点 分布在 1 个国家目标入组 53 人开始时间: 2018年9月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
53
试验地点
1
主要终点
Neuroimmune Signaling

研究概览

简要总结

This study will leverage extracted leukocyte DNA specimens from a completed NIH-funded project to examine the efficacy of a behavioral intervention model that reduced stimulant use on DNA methylation over 6 months.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • At least 18 years old
  • Documentation of HIV-positive serostatus
  • Speak English
  • Biological verification of recent methamphetamine use
  • Completion of at least three contingency management (CM) visits
  • Self reported anal sex with a man in the past 12 months

排除标准

  • Inability to provide informed consent, evidenced by cognitive impairment
  • HIV negative serostatus

结局指标

主要结局

Neuroimmune Signaling

时间窗: 6 Months

Decreased methylation of genes for genes relevant to neuroimmune signaling such as beta-2 (β2) adrenergic (i.e., ADRB2), glucocorticoid (i.e., NR3C1 and FKBP5), and oxytocin (i.e., OXTR) receptors as well as brain-derived neurotrophic factor (BDNF) promoters.

次要结局

  • DNA Methylation Pathways(6 Months)
  • Immune Dysfunction(6 Month)
  • Dysregulated Metabolism of Amino Acid Precursors for Neurotransmitters measured via high-performance liquid chromatography (HPLC)(6 Months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Adam Carrico, PhD

Professor and Chair

Florida International University

研究点 (1)

Loading locations...

相似试验

Stimulant Use and Methylation in HIV | 临床试验